Free Trial

IBEX (IBEX) Competitors

IBEX logo
$29.10 +0.60 (+2.11%)
As of 06/30/2025 04:00 PM Eastern

IBEX vs. NVEE, VVX, GB, TASK, OLO, UPBD, FLYW, ASTH, CRTO, and EVH

Should you be buying IBEX stock or one of its competitors? The main competitors of IBEX include NV5 Global (NVEE), V2X (VVX), Global Blue Group (GB), TaskUs (TASK), OLO (OLO), Upbound Group (UPBD), Flywire (FLYW), Astrana Health (ASTH), Criteo (CRTO), and Evolent Health (EVH). These companies are all part of the "business services" industry.

IBEX vs. Its Competitors

NV5 Global (NASDAQ:NVEE) and IBEX (NASDAQ:IBEX) are both small-cap business services companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, analyst recommendations, risk, profitability, valuation, earnings and dividends.

In the previous week, NV5 Global and NV5 Global both had 6 articles in the media. NV5 Global's average media sentiment score of 0.58 beat IBEX's score of 0.07 indicating that NV5 Global is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
NV5 Global
0 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
IBEX
1 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

NV5 Global has a beta of 1.14, meaning that its stock price is 14% more volatile than the S&P 500. Comparatively, IBEX has a beta of 0.78, meaning that its stock price is 22% less volatile than the S&P 500.

75.5% of NV5 Global shares are owned by institutional investors. Comparatively, 81.2% of IBEX shares are owned by institutional investors. 12.4% of NV5 Global shares are owned by company insiders. Comparatively, 6.7% of IBEX shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

IBEX has lower revenue, but higher earnings than NV5 Global. IBEX is trading at a lower price-to-earnings ratio than NV5 Global, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NV5 Global$941.27M1.64$27.98M$0.5046.18
IBEX$508.57M0.77$33.65M$2.2912.71

NV5 Global presently has a consensus price target of $25.67, indicating a potential upside of 11.16%. IBEX has a consensus price target of $27.00, indicating a potential downside of 7.22%. Given NV5 Global's stronger consensus rating and higher probable upside, equities research analysts plainly believe NV5 Global is more favorable than IBEX.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NV5 Global
0 Sell rating(s)
5 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.29
IBEX
0 Sell rating(s)
3 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

IBEX has a net margin of 6.93% compared to NV5 Global's net margin of 3.19%. IBEX's return on equity of 25.51% beat NV5 Global's return on equity.

Company Net Margins Return on Equity Return on Assets
NV5 Global3.19% 9.12% 5.84%
IBEX 6.93%25.51%12.67%

Summary

NV5 Global beats IBEX on 9 of the 15 factors compared between the two stocks.

Get IBEX News Delivered to You Automatically

Sign up to receive the latest news and ratings for IBEX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IBEX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IBEX vs. The Competition

MetricIBEXBUSINESS SVCS IndustryBusiness SectorNASDAQ Exchange
Market Cap$381.11M$6.00B$13.00B$8.90B
Dividend YieldN/A3.08%2.60%4.13%
P/E Ratio12.7121.7728.1719.67
Price / Sales0.771.9739.67110.29
Price / Cash8.9213.6224.0427.49
Price / Book3.025.246.265.42
Net Income$33.65M$150.49M$188.17M$248.34M
7 Day Performance2.18%0.22%1.07%0.81%
1 Month Performance1.39%1.77%3.49%5.01%
1 Year Performance82.33%64.60%25.68%18.10%

IBEX Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IBEX
IBEX
1.0871 of 5 stars
$29.10
+2.1%
$27.00
-7.2%
+79.9%$381.11M$508.57M12.7130,000
NVEE
NV5 Global
2.1713 of 5 stars
$23.09
+1.3%
$25.67
+11.2%
-0.7%$1.55B$941.27M46.655,024
VVX
V2X
4.0118 of 5 stars
$48.61
+0.6%
$62.80
+29.2%
+1.4%$1.54B$4.32B37.6816,100
GB
Global Blue Group
2.4476 of 5 stars
$7.47
-0.1%
$6.00
-19.7%
+55.0%$1.49B$545.29M20.192,160
TASK
TaskUs
1.4135 of 5 stars
$16.76
flat
$17.67
+5.4%
+25.9%$1.49B$994.98M27.4848,200Positive News
OLO
OLO
1.3068 of 5 stars
$8.96
+3.9%
$9.00
+0.4%
+102.7%$1.49B$284.94M448.22710News Coverage
High Trading Volume
UPBD
Upbound Group
4.5403 of 5 stars
$25.10
-1.5%
$34.50
+37.5%
-18.2%$1.45B$4.32B11.7811,970Positive News
FLYW
Flywire
4.2263 of 5 stars
$11.70
+2.5%
$15.00
+28.2%
-28.6%$1.42B$492.14M292.501,250
ASTH
Astrana Health
2.7276 of 5 stars
$24.88
+0.6%
$53.29
+114.2%
-38.7%$1.39B$2.25B34.561,900
CRTO
Criteo
4.1494 of 5 stars
$23.96
+0.5%
$46.70
+94.9%
-36.5%$1.39B$1.93B9.743,507
EVH
Evolent Health
1.7006 of 5 stars
$11.31
+1.3%
$17.79
+57.3%
-40.8%$1.33B$2.55B-9.204,500

Related Companies and Tools


This page (NASDAQ:IBEX) was last updated on 7/1/2025 by MarketBeat.com Staff
From Our Partners